Pure Global

Investigation of the Microbiome of the Cornea in Microbial Keratitis - Trial NCT04030403

Access comprehensive clinical trial information for NCT04030403 through Pure Global AI's free database. This phase not specified trial is sponsored by Liverpool University Hospitals NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Infectious Keratitis. Target enrollment is 241 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04030403
Not yet recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT04030403
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Investigation of the Microbiome of the Cornea in Microbial Keratitis
A Study of Infections of the Front of the Eye (Cornea)

Study Focus

Infectious Keratitis

Observational

Sponsor & Location

Liverpool University Hospitals NHS Foundation Trust

Timeline & Enrollment

N/A

Aug 01, 2019

Jul 01, 2022

241 participants

Primary Outcome

Differences in microorganisms identified between the affected eyes of microbial keratitis participants and control eyes.

Summary

Design: Prospective observational diagnostic study and methods-comparison.
 
 Aims:
 
 The overall aim of the project is to better define the pathogenic microorganisms in patients
 with microbial keratitis (MK) through a better understanding of the corneal and ocular
 surface microbiome in health and disease.
 
 This will be achieved through the following objectives:
 
 1. Using NGS, analyse the corneal microbiome of the affected and unaffected eye of patients
 with and without MK and compare with simultaneous results from CDC and MTPCR.
 
 2. Determine the microbiological spectrum of the cornea, ocular surface and contiguous
 structures, in patients with MK, healthy controls, contact lens wearers and eye drop
 users.
 
 Outcome measures:
 
 1. A comparison of isolation rates and identified bacteria obtained from CDC, MTPCR and NGS
 processing of MK corneal samples will be made.
 
 2. Microorganisms identified in the eyes with MK will be compared to the fellow eye and
 other control groups and subtractive bioinformatics methodology applied to identify the
 most likely pathogenic organisms compared to those seen in the healthy corneal and
 ocular surface microbiome.
 
 3. Comparisons of the relative abundance of microorganisms obtained from MK corneal samples
 over the participant's follow-up visits will be used to evaluate longitudinal changes in
 the corneal and ocular surface microbiome during treatment and resolution of MK.
 
 4. A direct comparison between the relative abundance of microorganisms isolated from
 participants cornea, conjunctiva, eyelids and nose (contiguous structures) will be made
 to identify any possible endogenous sources of infection for MK.
 
 Population Eligibility:
 
 - All patients aged 18 years and over presenting with unilateral clinically suspected MK
 to St. Paul's Eye Unit, The Royal Liverpool University Hospital.
 
 - Patients with keratoconus undergoing cross-linking, subjects with no history of MK,
 subjects with no history of MK who are contact lens wearers and subjects with no history
 of MK but who are on eye drop treatment for glaucoma.
 
 Duration: Three years.

ICD-10 Classifications

Keratitis
Keratitis, unspecified
Other keratitis
Herpesviral keratitis and keratoconjunctivitis
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere

Data Source

ClinicalTrials.gov

NCT04030403

Non-Device Trial